Hemoglobin A1c outperforms fasting glucose for risk prediction

Mar 03, 2010

Measurements of hemoglobin A1c (HbA1c) more accurately identify persons at risk for clinical outcomes than the commonly used measurement of fasting glucose, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health. HbA1c levels accurately predict future diabetes, and they better predict stroke, heart disease and all-cause mortality as well. The study appeared in the March 4, 2010, issue of New England Journal of Medicine.

As a diagnostic, "HbA1c has significant advantages over ," said Elizabeth Selvin, PhD, MPH, the study's lead author. The A1c test has low variability from day to day, levels are not as affected by stress and illness, it has greater stability and the patient is not required to fast before the test is performed.

This study is published on the heels of a major change in the way doctors diagnose diabetes. In January, the American Diabetes Association (ADA) published revised recommendations for the screening and diagnosis of diabetes. The revised recommendations include, for the first time, recommendations to use HbA1c to diagnose diabetes and also to identify people at risk of developing diabetes in the future, also known as "pre-diabetes."

The new findings can help doctors and patients interpret HbA1c test results. In the study, people with HbA1c levels between 5.0 to 5.5 percent were identified as being within "normal" range. The majority of the U.S. adult population is within this range. With each incremental HbA1c increase, the study found, the incidence of diabetes increased as well; those at a level of 6.5 percent or greater are considered diabetic, and those between 6.0 and 6.5 percent are considered at a "very high risk" (9 times greater than those at the "normal" range) for developing diabetes.

The revised ADA guidelines classify people with HbA1c levels in the range of 5.7 to 6.4 percent as "at very high risk" for developing diabetes over 5 years. The range of 5.5 to 6 percent, according to the ADA guidelines, is the appropriate level to initiate preventive measures.

The study measured in blood samples from more than 11,000 people, black and white adults, who had no history of diabetes. The samples were obtained between 1990 and 1992 as part of the Atherosclerosis Risk in Communities (ARIC) Study at four ARIC field centers in Hagerstown, Md. (the George W. Comstock Center for Public Health Research and Prevention), Minneapolis, Minn. (University of Minnesota), Jackson, Miss. (University of Mississippi Medical Center) and Forsyth County, N.C. (University of North Carolina). The samples have been in cold storage since their collection. "It is amazing to be able to use blood samples collected over a decade ago," said Selvin, because researchers were able to look at participants' measurements and compare to outcomes that occurred during 15 years of follow-up.

Currently there are 9 million Americans who are diabetic but undiagnosed. "These data," said Selvin "can help us interpret A1c values in clinical practice and help identify people who need treatment the most."

Explore further: Key milestone for brown fat research with a ground-breaking MRI scan

add to favorites email to friend print save as pdf

Related Stories

Intensive glucose control in diabetics reduces heart attacks

May 26, 2009

(PhysOrg.com) -- A meta-analysis of five trials has shown that more intensive glucose control in diabetes leads to fewer heart attacks and heart disease events - but has no significant effect on stroke or mortality from all ...

Obstructive sleep apnea may worsen diabetes

Jan 14, 2010

Obstructive Sleep Apnea (OSA) adversely affects glucose control in patients with type 2 diabetes, according to a study conducted by researchers at the University of Chicago.

Recommended for you

New pain relief targets discovered

6 hours ago

Scientists have identified new pain relief targets that could be used to provide relief from chemotherapy-induced pain. BBSRC-funded researchers at King's College London made the discovery when researching ...

Building 'smart' cell-based therapies

6 hours ago

A Northwestern University synthetic biology team has created a new technology for modifying human cells to create programmable therapeutics that could travel the body and selectively target cancer and other ...

Proper stem cell function requires hydrogen sulfide

9 hours ago

Stem cells in bone marrow need to produce hydrogen sulfide in order to properly multiply and form bone tissue, according to a new study from the Center for Craniofacial Molecular Biology at the Herman Ostrow School of Dentistry ...

User comments : 0

More news stories

Turning off depression in the brain

Scientists have traced vulnerability to depression-like behaviors in mice to out-of-balance electrical activity inside neurons of the brain's reward circuit and experimentally reversed it – but there's ...

Hackathon team's GoogolPlex gives Siri extra powers

(Phys.org) —Four freshmen at the University of Pennsylvania have taken Apple's personal assistant Siri to behave as a graduate-level executive assistant which, when asked, is capable of adjusting the temperature ...

Better thermal-imaging lens from waste sulfur

Sulfur left over from refining fossil fuels can be transformed into cheap, lightweight, plastic lenses for infrared devices, including night-vision goggles, a University of Arizona-led international team ...